British group AstraZeneca has admitted in court for the first time that some of its vaccines against 'Covid' cause fatal blood clots in the veins.
The local network Daily Mail writes that the rare side effect is at the center of a multi-million dollar compensation lawsuit by British citizens who have been maimed or have lost their loved ones to the pharmaceutical giant's 'defective' vaccines.
Cambridge-based company AstraZeneca, which disputes the claims, admitted in documents filed in February that in rare cases it causes fatal blood clots, known in Britain as TTS (thrombosis with thrombocytopenia symptoms).
This complication, listed as a side effect of the vaccine, was previously labeled as “vaccine-induced thrombocytopenia.” The admission made by AstraZeneca could now lead to individual damages in each case, writes the Daily Mail.
The development comes as the company announced profits of £10 billion in 2024 alone.
One of those seeking compensation is father-of-two IT engineer Jamie Scott, who has been left unable to work due to permanent brain injuries after receiving the vaccine in April 2021.
He is one of 51 cases in the lawsuit estimated to reach 100 million pounds.
His wife Kate Scott said: "I hope this admission brings a solution now even though it's late. We want an apology, compensation for us and other affected families, we're not giving up."
New documents showed a change in language used by AstraZeneca in past sessions, when the company insisted that the serious side effect could not have been caused by its vaccine "at the generic level".
Health officials have identified cases of blood-borne effects from the AstraZeneca vaccine in Europe since March 2021, just two months after the vaccine was released on the market.
By April, the evidence became clear and the vaccine began to be restricted, the media wrote.
Around 50 million doses of AstraZeneca have been injected in total in Britain.
edition
t7 live
